Diabeter is a certified diabetes center dedicated to providing comprehensive and individualized care for children and young adults with diabetes mellitus (mostly type 1). Based in the Netherlands, we are one of the largest specialized centers in Europe, currently managing well over 2,300 patients.
Conducting scientifically sound research that leads to a better understanding of type 1 diabetes and its treatment is an important goal of our work. By expanding knowledge about diabetes, we can help towards the development of new forms of treatment of the disease and its complications, as well as find ways to prevent or cure the disease.
“Aiming to deliver the best care for patients inevitably leads us to ask two questions: what is ’best’ and how can we do better? Overall, our work focuses on answering these questions, and keeping ahead of the latest developments in the field.” – Dick Mul, Diabeter
Several key principles form the basis of our approach to research:
The central theme of our research is to identify and characterize the heterogeneity of type 1 diabetes, and the implications for care. The “one-size-fits-all” approach to managing diabetes no longer applies. Type 1 diabetes is not a single disease, but comes in different ‘versions’. Differences in the age of onset, in the development of medical complications, and in the effects of treatments and interventions, point to an extensive heterogeneity and different disease stages. At Diabeter we can combine new research data with the extensive clinical datasets collected in our disease management system (Vcare). This allows us to dissect this heterogeneity, define the stages of the disease, and develop ways to apply this knowledge to new interventions that improve patient care.
Our research into heterogeneity focuses on three main areas:
The individual studies conducted within each of these areas are discussed in detail elsewhere on this site.
“The three main areas of research were chosen to ensure that we produce clinically relevant findings. Outcome data are crucial for identifying the need to adapt care, while insights from the heterogeneity research will enable us to better target specific treatments or (psychosocial) interventions to the individual patients who are most likely to benefit.” – Dick Mul, Diabeter
Diabeter has formed strong alliances with other institutions, enabling us to collaborate on research projects. Examples include work with:
If you would like more information about the work that we do, or have a specific question or proposal, please contact us via this website or email us at email@example.com.